ArticleTherapeutic advances in hematology2021

A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes.

Huan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.